|
|
Volumn 4, Issue 4, 2006, Pages 344-349
|
|
Short guildeline: Malignant melanoma of the skin;Kurzleitlinie: Malignes melanom der haut
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARMUSTINE;
CISPLATIN;
DACARBAZINE;
FOTEMUSTINE;
HYDROXYUREA;
INTERLEUKIN 2;
LOMUSTINE;
TAMOXIFEN;
TEMOZOLOMIDE;
VINCRISTINE;
VINDESINE;
CANCER ADJUVANT THERAPY;
CANCER CLASSIFICATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER IMMUNOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER RISK;
CANCER STAGING;
CANCER SURGERY;
CANCER THERAPY;
DIFFERENTIAL DIAGNOSIS;
DRUG CONTRAINDICATION;
DRUG DOSE REGIMEN;
DRUG INDICATION;
HUMAN;
LABORATORY TEST;
MELANOMA;
METASTASIS;
MONOTHERAPY;
PREOPERATIVE CARE;
PREOPERATIVE EVALUATION;
PROGNOSIS;
REVIEW;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
CLINICAL PRACTICE;
GERMANY;
PRACTICE GUIDELINE;
SKIN TUMOR;
STANDARD;
ANTINEOPLASTIC AGENTS;
GERMANY;
HUMANS;
MELANOMA;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES;
SKIN NEOPLASMS;
|
|
EID: 33646841804
PISSN: 16100379
EISSN: 16100387
Source Type: Journal
DOI: 10.1111/j.1610-0387.2006.05891.x Document Type: Review |
|
Times cited : (26)
|
|
References (1)
|
